ArticleJournal of clinical medicine2021

Benefits of a Disease Management Program for Sickle Cell Disease in Germany 2011-2019: The Increased Use of Hydroxyurea Correlates with a Reduced Frequency of Acute Chest Syndrome.

Joachim B Kunz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.